| Increased adoption of Impella heart pumps helps raise Abiomed’s quarterly revenue |
| Theranos CEO Elizabeth Holmes to speak at clinical chemistry conference |
| Mediterranean diet may improve cardiovascular outcomes |
| After a stroke, patients have increased risk of recurrent stroke, dementia |
| Female cardiologist in Maryland is 75 and still working 12-hour days |
| Boston Scientific posts sales increase in 2nd quarter, raises revenue guidance |
| Study on Apollo astronauts links deep space radiation to cardiovascular diseases |
| ACC, AHA comment on proposed bundled payments for cardiac care |
| Physical activity may lower coronary heart disease risk in younger women |
| Bristol-Myers Squibb settles whistleblower lawsuit for $30 million |
| Heart failure patients receiving sacubitril/valsartan have reduction in 30-day readmissions |
| CMS star ratings debut with promise for continued updates |
| TAVR growth helps Edwards post strong second quarter financial results |
| Patients with heart failure and improved or recovered ejection fraction may have improved outcomes |
| Shortage of donor hearts creates issues for physicians |
| With Abbott deal near completion, St. Jude Medical’s sales increase 11% |
| Flu vaccines associated with 24 percent all-cause death reduction in type 2 diabetes patients |
| CMS proposes bundled payments model for cardiac care |
| Abbott’s revenue increases 3.2% in second quarter |
| Heart transplant recipient becomes long distance runner |
| Endocrinologist responds to study suggesting low sodium intake may increase cardiovascular events |
| Meta-analysis finds no significant difference in mortality risk between diabetes medications |
| Cardiac Science releases new CPR support device |
| Texas health system opens cardiovascular center in response to study |
| Stryker recalls 167 angiographic catheters |
| Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRct Analysis to Assess Coronary Artery Disease |
| Madrigal, Synta complete merger |
| Medicare selects participants for new five-year cardiovascular initiative |
| Theranos hires executives, creates committee to oversee regulatory compliance |
| New research suggests cardiovascular mortality could be affected by the color of your skin |
| Surgeon specialization may predict 30-day operative mortality following cardiac procedures |
| FDA approves the Celt ACD vascular closure device |
| FDA approves generic versions of Crestor |
| CMS announces 516 participating organizations in program to reduce risk of MIs and strokes |
| PCORI provides $6.5 million in funding for comparative effectiveness research for anticoagulants |
| More than 17 percent of adolescents have prediabetes |
| Judge denies AstraZeneca’s request for exclusivity to sell blockbuster cholesterol medication |
| Systematic review finds evidence is lacking for percutaneous LAA exclusion as an alternative to oral anticoagulation |
| Adults who eat more subsidized foods may have an increase in cardiometabolic risk |
| Mortality rate remains high in patients undergoing PCI for an MI following noncardiac surgery |
| Mitral valve repair device 100 percent successful in first human clinical study |
| Fewer than 1/3 of eligible patients participate in cardiac rehabilitation programs |
| Novartis plans to invest $200 million this year to increase sales of heart failure medication |
| Bleeding risk associated with vitamin K antagonists only slightly increases past age 80 |
| Edwards names Leslie Heisz to board of directors |
| Scoring system may help predict 30-day and one-year mortality following TAVR |
| Palliative care is uncommon among heart failure patients |
| Penn Medicine study shows side effects of breast cancer drug |
| Study: More than 90 percent of strokes are preventable |
| Obese adults see improvements in blood pressure, cholesterol levels but worsening blood glucose health |
| USPSTF outlines research plan for examining the use of ECG to screen for CVD risk and atrial fibrillation |
| Federal court dismisses lawsuit, upholds settlement between Cardiovascular Systems and ex-salesman |
| Corpath System to be Featured for Complex Interventions at SDCI 2016: San Diego Cardiovascular Interventions Course |
| Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths |
| University of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite with Stereotaxis Niobe® ES System |
| Good Samaritan Hospital First on the West Coast to Offer Naturally Dissolving Heart Stent to Patients with Coronary Artery Disease |
| Trial examines the Tryton stent for use in patients with large side branches |
| First Coast's Proposed Cut In Reimbursement Rate Of Blood Test Threatens Heart Transplant Patient Care In Florida |
| Endotronix closes Series C round funding for development of artery sensor |
| Cardiologist Galen Wagner dies at age 76 |
| CMS grants IDE to MedStar for trial examining TAVR devices |
| Patients who develop heart failure after first MI have an increased risk of cancer |
| New research finds collagen to be tissue remodeling regulator |
| FDA approves system that provides once monthly dose of Amgen’s PCSK9 inhibitor |
| New transcatheter system boosts outlook for aortic stenosis patients, study suggests |
| Ex-Valeant CEO sells shares for nearly $100 million |
| FDA approves Medtronic’s drug-coated balloon in a longer length |
| New study shows atrial fibrillation related to smaller brain volumes |
| Alere recalls its PT/INR monitoring system |
| Boston Scientific elects former Lixil CEO to its board of directors |
| AHA releases list of drugs that may cause or exacerbate heart failure |
| Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis |
| Advance care planning video helps heart failure patients make informed decisions |
| FDA approves St. Jude Medical’s CRT software |
| Involving pharmacists in care decisions may reduce risk of cardiovascular disease |
| Mednax acquires Pediatric Cardiology Associates in cash deal |
| Report says Theranos CEO’s role will likely remain the same |
| AHA, Amazon collaborate on precision medicine initiative |
| Bernie Sanders, House Democrats urge FDA to approve generic versions of Crestor |
| Harvard researchers hope artificial stingray can help them engineer a human heart |
| ABIM appoints 10 cardiologists to specialty boards and exam committees |
| BayCare Health first to implant world’s smallest pacemaker |
| Pharmacist intervention in Canada reduces risk of cardiovascular events |
| Arizona marathon runner receives first dissolvable heart stent |
| Essential Medical gets FDA approval for vascular closure trial |
| CMS sanctions Theranos, prohibits CEO from operating a lab for two years |
| The presence of anemia in chronic heart failure patients worsens outcomes |
| Sudden cardiac death is more common in men than women |
| Cardiologist urges colleagues to vote for Donald Trump |
| Cardiologists claim PCIs may not be appropriate to treat stable ischemic heart disease |
| Registry analysis finds physicians prescribe oral anticoagulants at lower rate than expected |
| Prevalence of people living with congenital heart defects increases 40% from 2000 to 2010 |
| Investigational PCSK9 inhibitor significantly reduces LDL cholesterol in phase 3 trials |
| Valeant’s stock price continues to decrease under new CEO |
| Shortage of technetium Tc 99m leads to decrease in cardiac stress testing |
| Stentys hires Christophe Lottin as CEO |
| FDA approves Absorb, Abbott’s fully bioresorbable drug-eluting stent |
| Federal government indicts Kentucky cardiologist |
| AHA honors three longtime volunteers with the Gold Heart Award |
| Esperion Therapeutics’ shares fall after disclosing uncertain future for its cholesterol-lowering drug |
